AAAAAA

   
Results: 1-8 |
Results: 8

Authors: Petersenn, S Rasch, AC Penshorn, M Beil, FU Schulte, HM
Citation: S. Petersenn et al., Genomic structure and transcriptional regulation of the human growth hormone secretagogue receptor, ENDOCRINOL, 142(6), 2001, pp. 2649-2659

Authors: Bamberger, AM Schulte, HM Wullbrand, A Jung, R Beil, FU Bamberger, CM
Citation: Am. Bamberger et al., Expression of leukemia inhibitory factor (LIF) and LIF receptor (LIF-R) inthe human adrenal cortex: implications for steroidogenesis, MOL C ENDOC, 162(1-2), 2000, pp. 145-149

Authors: Petersenn, S Heyens, M Ludecke, DK Beil, FU Schulte, HM
Citation: S. Petersenn et al., Absence of somatostatin receptor type 2 A mutations and gip oncogene in pituitary somatotroph adenomas, CLIN ENDOCR, 52(1), 2000, pp. 35-42

Authors: Bamberger, CM Else, T Bamberger, AM Frilling, A Beil, FU Allolio, B Schulte, HM
Citation: Cm. Bamberger et al., Telomerase activity in benign and malignant adrenal tumors, EXP CL E D, 107(4), 1999, pp. 272-275

Authors: Bamberger, CM Fehn, M Bamberger, AM Ludecke, DK Beil, FU Saeger, W Schulte, HM
Citation: Cm. Bamberger et al., Reduced expression levels of the cell-cycle inhibitor p27(Kip1) in human pituitary adenomas, EUR J ENDOC, 140(3), 1999, pp. 250-255

Authors: Petersenn, S Penshorn, M Beil, FU Schulte, HM
Citation: S. Petersenn et al., Molecular analysis of the human growth hormone secretagogue receptor, MED KLIN, 94(4), 1999, pp. 202-206

Authors: Petersenn, S Rasch, AC Presch, S Beil, FU Schulte, HM
Citation: S. Petersenn et al., Genomic structure and transcriptional regulation of the human somatostatinreceptor type 2, MOL C ENDOC, 157(1-2), 1999, pp. 75-85

Authors: Bamberger, CM Else, T Bamberger, AM Beil, FU Schulte, HM
Citation: Cm. Bamberger et al., Dissociative glucocorticoid activity of medroxyprogesterone acetate in normal human lymphocytes, J CLIN END, 84(11), 1999, pp. 4055-4061
Risultati: 1-8 |